392 Followers on Owler

Veristat

Read more
Patrick Flanagan's photo - Chairman & CEO of Veristat

Chairman & CEO

Patrick Flanagan

CEO Approval Rating

69/100

Founded:

1994

Status:

PrivateIndependent Company

VERISTAT TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Patrick Flanagan

Chairman & CEO

- -
300
$0
$48.1M
View Profile
1

Allen Cato

Co-Founder & CEO

86/100
48
- -
$38M
View Profile
2

Curtis Head

Co-Founder & CEO

78/100
30
- -
$4M
View Profile
3

Chris O’Brien

CEO

- -
199
- -
$50M
View Profile
4

Nepton Sheik Khoni

CEO

70/100
12
- -
$5M
View Profile
5

Ludo Reynders

CEO

77/100
1,250
- -
$54M
View Profile
6

Benjamin M. Chien

Chairman & CEO

80/100
1,200
- -
$140M
View Profile
7

Timothy J. Schroeder

Chairman & CEO

82/100
1,000
$5M
$165M
View Profile
8

Gordana Greguric Cicak

Co-Founder & CEO

90/100
100
$11.5M
View Profile
9

Prabuddha Kundu

Managing Director

84/100
67
- -
$8.3M
View Profile
10

John M. Hudak

President

87/100
66
$150K
$9.5M
View Profile

Missing a competitor? Contribute!

Cato Research is a top competitor of Veristat. Cato Research is a Private company that was founded in 1988 in Durham, North Carolina. Cato Research operates in the Health Care Services industry. Compared to Veristat, Cato Research has 252 fewer employees.

PRC Clinical is seen as one of Veristat's biggest rivals. PRC Clinical was founded in 2003, and is headquartered in Burlingame, California. PRC Clinical operates in the Health Care Services industry. PRC Clinical generates $44.1M less revenue vs. Veristat.

Biorasi is seen as one of Veristat's top competitors. Biorasi was founded in Miami, Florida} in 2002. Biorasi competes in the Medical Research & Laboratories industry. Compared to Veristat, Biorasi generates $1.9M more revenue.

Veristat Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Syne Qua Non Limited

Feb 2021

Source »
undisclosed
SQN Clinical is a biometric contract research organization that provides medical writing and quality management services for pharmaceutical sector.
Certus PV Services, Inc.

Nov 2020

Source »
undisclosed
Certus PV is a consulting firm that provides pre-approval and post-market pharmacovigilance services for pharma, cosmetics and medical industries.
The CLINICAL TRIAL Company Ltd.

Jan 2020

Source »
undisclosed
TCTC is a Contract Research Organization that provides clinical development services for pharmaceutical and healthcare industries.
Catalyst Regulatory Services, LLC

Dec 2019

Source »
undisclosed
Catalyst Regulatory Services provides regulatory strategy consulting and document formatting services to the biotechnology sector.
Topstone Research

Oct 2018

Source »
undisclosed
Topstone is a contract research organization that offers project management, site feasibility, clinical monitoring and pharmacovigilance services.

These are all the companies that Veristat has acquired. Veristat has acquired 5 companies and its latest acquisition was Syne Qua Non Limited in Feb 2021. SQN Clinical is a biometric contract research organization that provides medical writing and quality management services for pharmaceutical sector.

Veristat Funding History

No recent funding data found related to Veristat

Veristat Investments

No recent investments found related to Veristat

Veristat News

Veristat Blogs

Veristat Press Releases

Social Media

Veristat Headquarters

134 Turnpike Road, Suite 200

Southborough, Massachusetts01772

508-429-7340

Driving Directions »

Trending Companies

Veristat Summary

ABOUT

Overview

Veristat is a clinical research organization that provides project management, medical writing and monitoring services for the pharmaceutical sector. Veristat was founded in 1994. Veristat's headquarters is located in Southborough, Massachusetts, USA ...

CEO

Veristat's Chairman & CEO, Patrick Flanagan, currently has an approval rating of 69%. Veristat's primary competitors are Cato Research, PRC Clinical & Biorasi.

Frequently Asked Questions about Veristat

  1. When was Veristat founded?

    Veristat was founded in 1994
  2. Who is Veristat's CEO?

    Veristat's CEO is Patrick Flanagan
  3. How much revenue does Veristat generate?

    Veristat generates $48.1M in revenue
  4. How much funding does Veristat have?

    Veristat has historically raised $0 in funding
  1. Where is Veristat's headquarters?

    Veristat's headquarters is in Southborough Massachusetts, USA
  2. How many employees does Veristat have?

    Veristat has 300 employees
  3. What sector does Veristat operate in?

    Veristat is in Pharmaceuticals
  4. Who are Veristat's competitors?

    Veristat's top competitors are Cato Research, PRC Clinical, Biorasi